Obinutuzumab for relapsed or refractory indolent non-Hodgkin’s lymphomas

Ludovic Gabellier, Guillaume Cartron
  • Therapeutic Advances in Hematology, December 2015, SAGE Publications
  • DOI: 10.1177/2040620715622613

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1177/2040620715622613

In partnership with: